These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8887842)

  • 1. Improving the coverage of neonatal BCG vaccination.
    Chappel D; Fernandes V
    J Public Health Med; 1996 Sep; 18(3):308-12. PubMed ID: 8887842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of neonatal BCG immunization within an acute hospital trust.
    Eastham KM; Wyllie J
    J Public Health Med; 2001 Dec; 23(4):335-8. PubMed ID: 11873898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering a selective neonatal BCG vaccination programme in a multi-ethnic community: an audit of the neonatal BCG immunisation programme in Birmingham and Solihull.
    Etuwewe O; Wood A; Lyon A
    Commun Dis Public Health; 2004 Sep; 7(3):172-6. PubMed ID: 15481207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage of childhood vaccination among children aged 12-23 months, Tamil Nadu, 2015, India.
    Murhekar MV; Kamaraj P; Kanagasabai K; Elavarasu G; Rajasekar TD; Boopathi K; Mehendale S
    Indian J Med Res; 2017 Mar; 145(3):377-386. PubMed ID: 28749402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis?
    Pharoah PD; Watson JM; Sen S
    Public Health; 1996 May; 110(3):179-83. PubMed ID: 8668765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
    Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new neonatal BCG vaccination pathway in England: a mixed methods evaluation of its implementation.
    Jones K; Chisnall G; Crocker-Buque T; Elliman D; Horwood J; Mounier-Jack S; Campbell CN; Saliba V; Chantler T
    BMC Public Health; 2024 Apr; 24(1):1175. PubMed ID: 38671383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy and practice--an audit of neonatal BCG immunization in Avon.
    Ahmed S; Hicks NR; Stanwell-Smith R
    J Public Health Med; 1992 Dec; 14(4):389-92. PubMed ID: 1489565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size.
    Floyd S; Ponnighaus JM; Bliss L; Warndorff DK; Kasunga A; Mogha P; Fine PE
    Int J Tuberc Lung Dis; 2000 Dec; 4(12):1133-42. PubMed ID: 11144455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974.
    Rousseau MC; Conus F; Kâ K; El-Zein M; Parent MÉ; Menzies D
    Vaccine; 2017 Aug; 35(36):4777-4784. PubMed ID: 28705514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
    Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
    Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG vaccination practices in Victoria.
    Altmann AE; Carnie JA
    Aust N Z J Public Health; 1996 Oct; 20(5):521-4. PubMed ID: 8987224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of BCG vaccination on tuberculin surveys to estimate the annual risk of tuberculosis infection in south India.
    Gopi PG; Subramani R; Nataraj T; Narayanan PR
    Indian J Med Res; 2006 Jul; 124(1):71-6. PubMed ID: 16926459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
    Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How good is our neonatal BCG uptake? A snapshot in Grampian.
    Shanks S; Duthie S
    J Public Health (Oxf); 2016 Jun; 38(2):e122-4. PubMed ID: 26205439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG immunisation in England and Wales: a survey of policy and practice in schoolchildren and neonates.
    Joseph CA; Watson JM; Fern KJ
    BMJ; 1992 Aug; 305(6852):495-8. PubMed ID: 1392994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the uptake of selective neonatal BCG immunisation.
    Gill J; Scott J
    Commun Dis Public Health; 1998 Dec; 1(4):281-2. PubMed ID: 9854891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India.
    Narayanan PR
    Indian J Med Res; 2006 Feb; 123(2):119-24. PubMed ID: 16575109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.